Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

January 21, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Type 2 DiabetesRenal Insufficiency
Interventions
DRUG

0.5 units/kg daily insulin

Participants randomized to receive this intervention will receive a standard-dose of 0.5 units/kg daily insulin. Half of this dose will be given as glargine and the other half will be given as glulisine.

DRUG

0.25 units/kg daily insulin

Participants randomized to receive this intervention will receive an experimental dose of 0.25 units/kg daily insulin. Half of this dose will be given as glargine and the other half will be given as glulisine.

Trial Locations (3)

60153

Loyola University Hospital, Maywood

60611

Northwestern University Medical Center, Chicago

60612

Rush University Medical Center, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Loyola University

OTHER